Skip to main content

Table 2 Univariate and multivariate analyses of immunohistochemical parameters (disease-free survival and overall survival)

From: A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer

  

Univariate

Multivariate

  

Total (n=142)

Hazard ratio

(95% CI)

P-value

Hazard ratio

(95% CI)

P-value

Disease-free survival

        

Ki67 LI

Low

98

1

  

1

  
 

High

44

3.6

1.7-7.9

0.0010

3.2

1.4-7.6

0.0073

p53

Negative

122

1

  

1

  
 

Positive

20

5.2

2.3-11.9

<0.0001

3.9

1.6-9.4

0.0025

FOXA1

Low

20

1

  

1

  
 

High

119

1.4

0.51-3.6

0.54

1.7

0.56-5.2

0.34

GATA3

Negative

30

1

  

1

  
 

Positive

112

1.5

0.65-3.5

0.34

1.2

0.46-3.4

0.66

Basal phenotype marker

Negative

133

1

  

1

  

(CK5/6, CK14, EGFR)

Positive

9

1.0

0.24-4.3

0.98

0.47

0.10-2.2

0.34

P-cadherin

Low

90

1

  

1

  
 

High

52

1.3

0.59-2.8

0.52

0.87

0.37-2.1

0.75

Overall survival

        

Ki67 LI

Low

98

1

  

1

  
 

High

44

4.4

1.3-14.6

0.016

3.2

0.91-11.9

0.070

p53

Negative

122

1

  

1

  
 

Positive

20

5.7

1.8-18.0

0.0029

3.8

1.1-13.0

0.030

FOXA1

Low

20

1

  

1

  
 

High

119

0.49

0.06-3.9

0.50

0.75

0.07-7.5

0.81

GATA3

Negative

30

1

  

1

  
 

Positive

112

1.1

0.31-4.3

0.84

1.3

0.29-6.1

0.70

Basal phenotype marker

Negative

133

1

  

1

  

(CK5/6, CK14, EGFR)

Positive

9

1.2

0.15-9.3

0.86

0.60

0.07-5.4

0.64

P-cadherin

Low

90

1

  

1

  
 

High

52

1.8

0.57-5.5

0.32

1.2

0.36-4.2

0.73

  1. Abbreviation: 95% CI 95% confidence interval, LI labeling index.